Benchmark Reaffirms “Buy” Rating for Medicine Man Technologies (OTC:SHWZ)

Benchmark reissued their buy rating on shares of Medicine Man Technologies (OTC:SHWZ) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $2.50 price objective on the stock.

Medicine Man Technologies Price Performance

SHWZ opened at $0.18 on Wednesday. Medicine Man Technologies has a 52 week low of $0.01 and a 52 week high of $1.55. The firm’s 50-day moving average is $0.28.

Medicine Man Technologies Company Profile

Medicine Man Technologies, Inc, doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes.